Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR4F21 Inhibitors

OR4F21 inhibitors are a specialized class of chemical compounds designed to target the OR4F21 receptor, part of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR4F21 are primarily known for their role in detecting odor molecules, but their expression in non-olfactory tissues suggests that they may have additional functions in various biological processes. OR4F21 inhibitors work by binding to this receptor, effectively blocking or altering its interaction with natural ligands. This inhibition can lead to changes in the receptor's signaling pathways, which may impact a variety of cellular functions. The study of OR4F21 inhibitors is crucial for understanding the broader biological roles of this receptor, especially in tissues where its function remains unclear. The chemical characteristics of OR4F21 inhibitors can vary, encompassing a range of structural classes and mechanisms of action. Some inhibitors are designed to act as competitive antagonists, binding directly to the receptor's active site to prevent the binding of natural ligands. This direct competition can effectively block the receptor's activity. Other inhibitors may work allosterically, binding to different sites on the receptor and inducing conformational changes that diminish its signaling capacity. The design and development of OR4F21 inhibitors often involve advanced techniques such as X-ray crystallography, cryo-electron microscopy, and computational modeling to identify potential binding sites and optimize the interactions between the inhibitors and the receptor. Researchers focus on creating inhibitors that are highly selective for OR4F21, ensuring that they specifically target this receptor without affecting other GPCRs or unrelated proteins. This selective targeting is essential for studying the specific roles of OR4F21 in various biological systems and for understanding how modulating its activity can influence different physiological processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a non-selective beta-adrenergic receptor blocker, illustrating how GPCR activity can be modulated by antagonists.

Atropine

51-55-8sc-252392
5 g
$200.00
2
(1)

Atropine is a muscarinic acetylcholine receptor antagonist, another example of a GPCR inhibitor.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

Cimetidine is a histamine H2 receptor antagonist, used to reduce stomach acid production by inhibiting a specific GPCR.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$80.00
$326.00
1
(0)

Ondansetron is a selective 5-HT3 receptor antagonist, showing targeted GPCR inhibition for therapeutic purposes.

Losartan

114798-26-4sc-353662
100 mg
$127.00
18
(1)

Losartan is an angiotensin II receptor antagonist.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Salmeterol is a long-acting beta2-adrenergic agonist, indicating GPCR activation for therapeutic effects.

Aripiprazole

129722-12-9sc-207300
sc-207300A
sc-207300B
100 mg
1 g
5 g
$175.00
$208.00
$1017.00
3
(1)

Aripiprazole acts as a partial agonist at dopamine D2 receptors, illustrating partial agonist activity at GPCRs.

Olmesartan acid

144689-24-7sc-219481
sc-219481A
sc-219481B
sc-219481C
sc-219481D
10 mg
500 mg
1 g
2 g
5 g
$153.00
$204.00
$326.00
$523.00
$1051.00
7
(1)

Olmesartan is an angiotensin II receptor antagonist, used for hypertension, targeting a specific GPCR.

Clozapine

5786-21-0sc-200402
sc-200402A
50 mg
500 mg
$68.00
$357.00
11
(1)

Clozapine is an antipsychotic that acts on various GPCRs, showing how one drug can affect multiple GPCRs.

Salbutamol

18559-94-9sc-253527
sc-253527A
25 mg
50 mg
$92.00
$138.00
(1)

Albuterol is a short-acting beta2-adrenergic agonist, used in bronchodilation, demonstrating GPCR activation.